Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL)
CUSIP: 05337M104
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share
- Shares outstanding
- 98,762,388
- Total 13F shares
- 737,501
- Share change
- 0
- Total reported value
- $6,526,891
- Price per share
- $8.85
- Number of holders
- 3
Quarterly Holders Quick Answers
What is CUSIP 05337M104?
CUSIP 05337M104 identifies AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05337M104:
Top shareholders of AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
14%
|
13,592,334
|
$108,839,643 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13D/G
13F
|
Company |
7%
|
6,742,480
|
$59,674,993 | $0 | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13D/G
13F
|
The Vanguard Group · Company |
5.7%
|
5,564,259
|
$49,243,692 | $0 | 30 Jun 2025 | |
| Jeffrey L. Gendell |
13F
|
Individual |
6.4%
|
6,127,156
|
$47,975,631 | — | 31 Mar 2025 | |
| BRANDES INVESTMENT PARTNERS, LP |
13F
|
Company |
5.9%
|
5,667,175
|
$44,373,981 | — | 31 Mar 2025 | |
| Two Seas Capital LP |
13F
|
Company |
5.2%
|
4,946,449
|
$38,730,696 | — | 31 Mar 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
4.5%
|
4,355,964
|
$34,107,198 | — | 31 Mar 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
2.8%
|
2,684,109
|
$21,016,573 | — | 31 Mar 2025 | |
| WEALTH EFFECTS LLC |
13F
|
Company |
2.5%
|
2,369,122
|
$18,550,227 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.3%
|
2,245,010
|
$17,578,429 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.2%
|
2,097,500
|
$16,423,425 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.7%
|
1,659,306
|
$12,992,366 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
1.3%
|
1,294,632
|
$10,136,969 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
1,189,596
|
$9,314,488 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.2%
|
1,118,090
|
$8,754,645 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
1,034,614
|
$8,101,034 | — | 31 Mar 2025 | |
| Samsara BioCapital, LLC |
13F
|
Company |
1%
|
967,527
|
$7,575,736 | — | 31 Mar 2025 | |
| Krensavage Asset Management, LLC |
13F
|
Company |
0.99%
|
950,000
|
$7,439,000 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.93%
|
896,861
|
$7,022,422 | — | 31 Mar 2025 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.79%
|
754,043
|
$5,904,157 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.76%
|
727,869
|
$5,699,214 | — | 31 Mar 2025 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.7%
|
676,632
|
$5,298,029 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.67%
|
639,866
|
$5,010,151 | — | 31 Mar 2025 | |
| Knoll Capital Management, LLC |
13F
|
Company |
0.61%
|
600,000
|
$4,698,000 | — | 31 Mar 2025 | |
| Modera Wealth Management, LLC |
13F
|
Company |
0.58%
|
558,977
|
$4,376,790 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.54%
|
517,939
|
$4,055,463 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.53%
|
504,790
|
$3,952,506 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.52%
|
494,678
|
$3,873,329 | — | 31 Mar 2025 | |
| David M. Knott Jr. |
13F
|
Individual |
0.44%
|
426,000
|
$3,335,580 | — | 31 Mar 2025 | |
| Altium Capital Management LLC |
13F
|
Company |
0.44%
|
419,131
|
$3,281,796 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.39%
|
375,241
|
$2,938,137 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.36%
|
341,000
|
$2,670,030 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.35%
|
334,925
|
$2,622,463 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.33%
|
314,343
|
$2,461,306 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.29%
|
279,877
|
$2,191,437 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.28%
|
266,085
|
$2,083,446 | — | 31 Mar 2025 | |
| Caption Management, LLC |
13F
|
Company |
0.28%
|
264,910
|
$2,074,245 | — | 31 Mar 2025 | |
| IRIDIAN ASSET MANAGEMENT LLC/CT |
13F
|
Company |
0.26%
|
249,586
|
$1,954,258 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.24%
|
234,120
|
$1,833,159 | — | 31 Mar 2025 | |
| Invenomic Capital Management LP |
13F
|
Company |
0.24%
|
228,026
|
$1,785,444 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.24%
|
226,439
|
$1,773,017 | — | 31 Mar 2025 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.23%
|
225,168
|
$1,763,065 | — | 31 Mar 2025 | |
| AVANTAX ADVISORY SERVICES, INC. |
13F
|
Company |
0.23%
|
222,733
|
$1,743,999 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.23%
|
221,348
|
$1,733,156 | — | 31 Mar 2025 | |
| J. Goldman & Co LP |
13F
|
Company |
0.23%
|
216,000
|
$1,691,280 | — | 31 Mar 2025 | |
| MML INVESTORS SERVICES, LLC |
13F
|
Company |
0.2%
|
194,306
|
$1,521,000 | — | 31 Mar 2025 | |
| DARK FOREST CAPITAL MANAGEMENT LP |
13F
|
Company |
0.19%
|
179,437
|
$1,404,992 | — | 31 Mar 2025 | |
| Swiss National Bank |
13F
|
Company |
0.18%
|
168,000
|
$1,315,440 | — | 31 Mar 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.16%
|
150,451
|
$1,178,034 | — | 31 Mar 2025 | |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV |
13F
|
Company |
0.15%
|
139,975
|
$1,096,004 | — | 31 Mar 2025 |
Institutional Holders of Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL) as of Q2 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.